| Primary |
| Pulmonary Arterial Hypertension |
49.8% |
| Pulmonary Hypertension |
33.7% |
| Cor Pulmonale Chronic |
4.8% |
| Prophylaxis |
2.2% |
| Product Used For Unknown Indication |
1.2% |
| Cardiac Failure |
0.8% |
| Hypertension |
0.8% |
| Atrial Fibrillation |
0.7% |
| Depression |
0.7% |
| Pain |
0.7% |
| Constipation |
0.6% |
| Diuretic Therapy |
0.6% |
| Headache |
0.6% |
| Primary Pulmonary Hypertension |
0.6% |
| Pulmonary Embolism |
0.4% |
| Pulmonary Fibrosis |
0.4% |
| Scleroderma |
0.4% |
| Stomatitis |
0.4% |
| Anticoagulant Therapy |
0.3% |
| Arrhythmia |
0.3% |
|
| Death |
26.8% |
| Hospitalisation |
7.3% |
| Pneumonia |
7.3% |
| Dyspnoea |
7.0% |
| Vision Blurred |
5.4% |
| Visual Impairment |
4.9% |
| Vomiting |
4.3% |
| Atrial Fibrillation |
3.5% |
| Cardiac Failure |
3.2% |
| Fluid Retention |
3.2% |
| Headache |
3.2% |
| Off Label Use |
3.2% |
| Pulmonary Hypertension |
3.0% |
| Syncope |
3.0% |
| Hypotension |
2.7% |
| Oedema Peripheral |
2.7% |
| Right Ventricular Failure |
2.7% |
| Cardiac Failure Congestive |
2.4% |
| Pulmonary Arterial Hypertension |
2.2% |
| Gastrointestinal Haemorrhage |
1.9% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
45.0% |
| Prophylaxis |
11.3% |
| Pulmonary Hypertension |
9.0% |
| Product Used For Unknown Indication |
6.4% |
| Stomatitis |
3.4% |
| Cardiac Failure |
3.0% |
| Rhinitis Allergic |
2.5% |
| Hypokalaemia |
2.1% |
| Cor Pulmonale Chronic |
1.9% |
| Vitamin Supplementation |
1.9% |
| Arrhythmia |
1.8% |
| Infection Prophylaxis |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Constipation |
1.2% |
| Gastritis |
1.2% |
| Haemorrhoids |
1.2% |
| Iron Deficiency Anaemia |
1.2% |
| Muscle Spasms |
1.2% |
| Vomiting |
1.2% |
| Cough |
1.1% |
|
| Multi-organ Failure |
7.8% |
| Pneumonia |
7.8% |
| Syncope |
7.8% |
| Oedema Peripheral |
6.7% |
| Unevaluable Event |
6.7% |
| Anaemia Neonatal |
5.6% |
| Death |
5.6% |
| Headache |
5.6% |
| Neonatal Respiratory Distress Syndrome |
5.6% |
| Vomiting |
5.6% |
| Malaise |
4.4% |
| Pulmonary Hypertension |
4.4% |
| Arthralgia |
3.3% |
| Deafness |
3.3% |
| Disease Progression |
3.3% |
| Fluid Retention |
3.3% |
| Pyrexia |
3.3% |
| Right Ventricular Failure |
3.3% |
| Swollen Tongue |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
57.2% |
| Product Used For Unknown Indication |
17.4% |
| Pulmonary Hypertension |
14.4% |
| Cor Pulmonale Chronic |
3.7% |
| Scleroderma |
1.5% |
| Heart Disease Congenital |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Portopulmonary Hypertension |
0.6% |
| Connective Tissue Disorder |
0.5% |
| Systemic Lupus Erythematosus |
0.5% |
| Systemic Sclerosis |
0.4% |
| Atrial Septal Defect |
0.3% |
| Hepatic Cirrhosis |
0.3% |
| Hypertension |
0.3% |
| Interstitial Lung Disease |
0.3% |
| Prophylaxis |
0.3% |
| Right Ventricular Failure |
0.3% |
| Coronary Artery Disease |
0.3% |
| Neuralgia |
0.2% |
| Atrial Fibrillation |
0.2% |
|
| Death |
24.6% |
| Pneumonia |
13.2% |
| Dyspnoea |
9.0% |
| Pulmonary Arterial Hypertension |
6.5% |
| Syncope |
5.1% |
| Unevaluable Event |
4.0% |
| Vomiting |
3.9% |
| Renal Failure |
3.5% |
| Pulmonary Hypertension |
3.0% |
| Pulmonary Oedema |
2.8% |
| Respiratory Failure |
2.8% |
| Device Related Infection |
2.6% |
| Right Ventricular Failure |
2.6% |
| Lung Transplant |
2.6% |
| Pyrexia |
2.6% |
| Weight Decreased |
2.5% |
| Fluid Retention |
2.4% |
| Infection |
2.1% |
| Chest Pain |
2.0% |
| Weight Increased |
1.9% |
|
